The clinical utility of viral quantitation using molecular methods. (Q54133163)

25 May 2018

review article

1 reference

title

The clinical utility of viral quantitation using molecular methods. (English)

1 reference

25 May 2018

author name string

Hodinka RL

series ordinal

1

1 reference

25 May 2018

publication date

1 May 1998

1 reference

25 May 2018

Clinical and diagnostic virology

published in

1 reference

25 May 2018

volume

10

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

25-47

1 reference

25 May 2018

The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Rapid and simple method for purification of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of four methods for quantitative measurement of hepatitis B viral DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Viral infections in severely immunocompromised cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitative or semi-quantitative PCR: reality versus myth

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantification of human cytomegalovirus DNA using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leuckocytes from AIDS patients with human cytomegalovirus viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Evaluation of Two Methods for Quantitation of Hepatitis C Virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A Pilot Study to Evaluate the Development of Resistance to Nevirapine in Asymptomatic Human Immunodeficiency Virus-Infected Patients with CD4 Cell Counts of >500/mm3 : AIDS Clinical Trials Group Protocol 208

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Toward routine diagnosis of hepatitis B virus desoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of quantitative HCV RNA assays in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of assays for HCV RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Measuring hepatitis C viremia in clinical samples: Can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Correlation between HIV provirus burden and in utero transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

To treat or not to treat? The judicious use of interferon-alpha-2a for the treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Intermethod variation in detection of human papillomavirus DNA in cervical smears

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

The application of quantitative polymerase chain reaction to therapeutic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Markers predicting progression of human immunodeficiency virus-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Hepatitis B virus. New and evolving issues

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Comparison of methods for detection of hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900016-6

7 January 2021

10.1016/S0928-0197(98)00016-6

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018